Cargando…
Early Elevation of Thioredoxin-1 Serum Levels Predicts 28-Day Mortality in Patients with Sepsis
BACKGROUND: Sepsis is the leading cause of death in critically ill patients, and the prevention of which requires precise outcome prediction and early intervention. We evaluated the prognostic prediction value of serum thioredoxin-1 (Trx-1) as an anti-inflammatory factor in patients with sepsis. MET...
Autores principales: | Li, Xing, Shen, Hua, Zhou, Tinghong, Cao, Xiaoyu, Chen, Ying, Liang, Yan, Lu, Ting, He, JiaFen, Dou, ZhouLin, Liu, ChuaiKai, Tang, Yong, Zhu, Zeixang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364846/ https://www.ncbi.nlm.nih.gov/pubmed/34408466 http://dx.doi.org/10.2147/JIR.S320419 |
Ejemplares similares
-
Does an increase in serum FGF21 level predict 28-day mortality of critical patients with sepsis and ARDS?
por: Li, Xing, et al.
Publicado: (2021) -
Early Elevation of Thioredoxin-1 Serum Levels Predicts 28-Day Mortality in Patients with Sepsis [Corrigendum]
Publicado: (2021) -
Elevated circulating PCSK9 level is associated with 28-day mortality in patients with sepsis: a prospective cohort study
por: Shu, Yuanlu, et al.
Publicado: (2023) -
Activated protein C, severe sepsis and 28-day mortality
por: De La Torre-Prados, M, et al.
Publicado: (2012) -
High 28-day mortality in critically ill patients with sepsis and concomitant active cancer
por: Wang, Yong-gang, et al.
Publicado: (2018)